| Variable | Crude OR (95% CI) | Adjusted OR† (95% CI) |
|---|---|---|
| Sex, female (v. male) | 0.96 (0.47–1.99) | – |
| Years of practice ≥ 21 (v. < 21) | 1.26 (0.41– 3.81) | 0.70 (0.17–2.84) |
| Other medical specialty (v. family physician/general practitioner) | 0.17 (0.07–0.43) | 0.14 (0.01– 1.71) |
| Work environment frequented in past year (yes v. no) | ||
| Hospital environment (excluding emergency department) | 0.35 (0.16–0.75) | 1.90 (0.42–8.51) |
| Family medicine group or unit | 3.21 (1.48–6.96) | 1.52 (0.40–5.86) |
| Emergency department | 1.17 (0.49–2.78) | – |
| Private medical office | 2.28 (0.86–6.00) | 1.33 (0.29–6.15) |
| % of medical practice dedicated to seeing patients in past year, per 10% increase in proportion | 1.01 (0.99–1.03) | – |
| No. of patients seen each week in medical practice, per 1-patient increase in weekly caseload | 1.02 (1.01–1.02) | 1.01 (0.99–1.02) |
| Perception of CNCP prevalence among clientele, per 10% increase in perceived prevalence | 1.03 (1.01–1.05) | 1.01 (0.98–1.04) |
| > 10% of CME activities about CNCP in past year (v. ≤ 10%) | 1.04 (0.27–3.95) | – |
| ≥ 1% of CME activities about cannabinoids in past year (v. 0%) | 1.66 (0.48–5.67) | – |
| Level of comfort with prescribing cannabinoids for CNCP, per 1-point increase on comfort scale | 2.04 (1.64–2.54) | 1.25 (1.01–1.55) |
Note: CI = confidence interval, CME = continuing medical education, OR = odds ratio. *Unless stated otherwise. †Adjusted for other factors in the table included in the multivariate model.